Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Genomic Profiling”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05099068
What this trial is testing

Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)

Who this might be right for
Advanced / Metastic Solid TumorsGlioblastomaChronic Leukemia Lymphocytic
Centre Leon Berard 500
Testing effectiveness (Phase 2)Study completedNCT02899793
What this trial is testing

Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer

Who this might be right for
Recurrent Endometrial Cancer
Yale University 25
Not applicableEnrolling By InvitationNCT06848738
What this trial is testing

Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound

Who this might be right for
Lung CancerLymphomaSarcoidosis
Zealand University Hospital 362
Not applicableActive Not RecruitingNCT05889195
What this trial is testing

Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria

Who this might be right for
Urothelial Carcinoma
Pacific Edge Limited 1,000
Not applicableStudy completedNCT03512847
What this trial is testing

Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung Cancer

Who this might be right for
Metastatic Nonsmall Cell Lung Cancer
Zealand University Hospital 150
Not applicableStudy completedNCT03766672
What this trial is testing

Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique

Who this might be right for
Endometrial Neoplasms
University Hospital Center of Martinique 30
Not applicableLooking for participantsNCT06020625
What this trial is testing

Mutational Oncology in Clinical Practice

Who this might be right for
Genome InstabilityGenetic Predisposition to DiseaseGene Rearrangement
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20,000
Early research (Phase 1)Looking for participantsNCT05857969
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more
Florida International University 65
Not applicableStudy completedNCT02628379
What this trial is testing

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

Who this might be right for
Neoplasms, Unknown PrimaryCUPMetastatic Disease+3 more
Foundation Medicine 125
Not applicableUnknownNCT00903565
What this trial is testing

A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint

Who this might be right for
Colon Cancer
Agendia 1,200
Not applicableWithdrawnNCT03080428
What this trial is testing

Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer

Who this might be right for
ER-positive Her2-negative Early Breast Cancer
UNICANCER
Testing effectiveness (Phase 2)Study completedNCT03732703
What this trial is testing

Myeloma-Developing Regimens Using Genomics (MyDRUG)

Who this might be right for
Relapsed Refractory Multiple Myeloma
Multiple Myeloma Research Consortium 103
Not applicableUnknownNCT02749838
What this trial is testing

Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens

Who this might be right for
Cancer
Pharmatech 183
Not applicableLooking for participantsNCT06991946
What this trial is testing

Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain

Who this might be right for
Metastatic Breast Cancer
SOLTI Breast Cancer Research Group 300
Not applicableLooking for participantsNCT06289270
What this trial is testing

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

Who this might be right for
Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer Tissues
Theodor Bilharz Research Institute 38
Not applicableUnknownNCT03375437
What this trial is testing

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

Who this might be right for
Soft Tissue SarcomaAdvanced CancerMetastatic Cancer
Centre Leon Berard 376
Not applicableStudy completedNCT05032092
What this trial is testing

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

Who this might be right for
Locally Advanced CarcinomaMetastatic Cancer
Medical University of Graz 235
Not applicableStudy completedNCT01919749
What this trial is testing

A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Translational Drug Development 25
Not applicableLooking for participantsNCT00200486
What this trial is testing

Molecular and Genomic Profiling of Head and Neck Tumors

Who this might be right for
Head and Neck Neoplasms
Montefiore Medical Center 1,000
Not applicableNot Yet RecruitingNCT06871501
What this trial is testing

"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"

Who this might be right for
Breast Cancer
Consorzio Oncotech 1,000
Next Page